Eli Lilly misses first-quarter estimates for earnings but beats the same for sales. Mounjaro and Zepbound sales beat ...

Novo Nordisk NVO and Eli Lilly LLY dominate ... as Ozempic pre-filled pen and Rybelsus oral tablet for type II diabetes and as Wegovy injection for weight management. Lilly’s Cardiometabolic ...

The new authorisation has been granted for a single-dose, pre-filled pen device that requires ... when compared with Bydureon and Eli Lilly’s Trulicity. Market analysts suggest that Novo Nordisk ...

Saxenda – which comes as prefilled self-injection pen – will be used as part ... Ozempic is squaring off in the market against Eli Lilly’s Trulicity (dulaglutide), which grew 22% to $3. ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed ...

In 2025, Lilly also expects an unfavorable impact from foreign exchange rates on the top line. Sales of Trulicity are likely to have been hurt by competitive dynamics and lower realized prices in ...